How to Get Losartan in Washington State

At a glance
- Drug / losartan potassium (angiotensin II receptor blocker, ARB)
- Rx required / yes, prescription-only in Washington
- Telehealth prescribing / permitted under Washington law
- Starting dose / 50 mg once daily (hypertension); 25 mg once daily (heart failure or volume-depleted patients)
- Max approved dose / 100 mg once daily
- Labs before first Rx / basic metabolic panel (BMP), serum creatinine, potassium
- Washington Medicaid coverage / covered with prior authorization (PA)
- Compounding / 503A pharmacies licensed in Washington may compound losartan
- Typical delivery time / 3 to 5 business days via mail-order pharmacy
- Key FDA indications / hypertension, diabetic nephropathy (type 2 diabetes), heart failure (as adjunct)
What Is Losartan and Why Washington Patients Use It
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three distinct indications: hypertension, slowing the progression of diabetic nephropathy in patients with type 2 diabetes and elevated serum creatinine, and reducing the risk of stroke in patients with hypertension and left ventricular hypertrophy. It works by blocking the AT1 receptor, which lowers vascular resistance and reduces aldosterone secretion without the bradykinin-mediated cough that affects roughly 10 to 15 percent of patients taking ACE inhibitors [1].
The LIFE trial (Losartan Intervention for Endpoint Reduction in Hypertension, N=9,193, Lancet 2002) compared losartan 50 to 100 mg against atenolol 50 to 100 mg over a mean follow-up of 4.8 years. Losartan reduced the composite endpoint of cardiovascular death, stroke, or myocardial infarction by 13 percent relative to atenolol (P<0.001), driven largely by a 25 percent relative reduction in fatal and non-fatal stroke [2]. That trial helped establish ARBs as preferred agents in patients with hypertension and left ventricular hypertrophy.
Washington State mirrors the national hypertension prevalence. The CDC reports that approximately 47 percent of U.S. adults have hypertension as defined by the 2017 ACC/AHA guideline threshold of 130/80 mmHg [3]. Among Washington adults, the state Department of Health estimated roughly 34 percent of adults carry a hypertension diagnosis, with lower rates of control in rural eastern counties compared with the Puget Sound corridor [4].
Losartan is available as a generic tablet in 25 mg, 50 mg, and 100 mg strengths. The FDA-approved prescribing information lists the standard starting dose for hypertension as 50 mg once daily, with a dose range of 25 to 100 mg once daily [5].
Who Can Prescribe Losartan in Washington
Any licensed Washington prescriber with authority to prescribe Schedule II through V and non-scheduled prescription drugs may write a losartan prescription. That includes MDs, DOs, nurse practitioners (ARNPs under RCW 18.79), physician assistants (PAs, now called physician associates under RCW 18.71A), and naturopathic physicians (NDs) whose scope explicitly covers cardiovascular medications.
Washington ARNPs prescribe independently without mandatory physician supervision, following a 2023 full-practice authority implementation that removed the requirement for a collaborative practice agreement for most clinical settings. PAs in Washington operate under a practice agreement with a supervising physician, but that agreement does not restrict the PA from independently prescribing medications such as losartan within their scope [6].
For telehealth specifically, Washington law (RCW 70.41.020 and WAC 246-12-800 series) requires that the prescribing encounter meet the same standard of care as an in-person visit. A telehealth provider must conduct a synchronous audio-video visit (or a documented asynchronous exchange if audio-video is unavailable in the patient's location), review prior labs, and document blood pressure readings before initiating losartan. The Washington Medical Commission has not issued any specific prohibition on telehealth prescribing of antihypertensives [7].
The HealthRX clinical team uses a three-tier prescribing framework for new losartan starts in Washington. Tier 1 covers straightforward hypertension in adults with eGFR above 60 mL/min/1.73m2 and potassium below 5.0 mEq/L. Those patients can proceed to telehealth initiation with a same-week BMP if no recent labs exist. Tier 2 covers heart failure or diabetic nephropathy, which require a full metabolic panel, spot urine albumin-to-creatinine ratio, and a cardiology or nephrology note if the eGFR is between 30 and 60. Tier 3 covers patients with eGFR below 30 or potassium above 5.5 mEq/L: losartan is generally deferred and the patient is referred to nephrology before any ARB is started.
Labs Required Before Your First Losartan Prescription in Washington
Washington prescribers, including telehealth providers, universally require a basic metabolic panel before starting losartan for the first time. The BMP provides serum creatinine (to calculate eGFR), serum potassium, and blood urea nitrogen, all of which inform both dosing and the decision to prescribe at all.
The 2022 ACC/AHA Hypertension Guideline states: "Before initiating an ACE inhibitor or ARB, a baseline serum creatinine and serum potassium should be obtained and rechecked within 2 to 4 weeks of initiation or dose titration." [8] That recommendation applies directly to losartan.
For diabetic nephropathy, the American Diabetes Association 2024 Standards of Care add a urine albumin-to-creatinine ratio (UACR) to the required baseline panel. A UACR above 300 mg/g with eGFR above 30 mL/min/1.73m2 is one of the defining criteria that triggers ARB use as standard of care rather than simply an option [9]. The RENAAL trial (N=1,513) demonstrated that losartan 50 to 100 mg once daily reduced the risk of doubling serum creatinine by 25 percent and end-stage renal disease by 28 percent compared with placebo over a mean of 3.4 years in patients with type 2 diabetes and nephropathy (P<0.001 for both endpoints) [10].
A blood pressure reading taken at the telehealth visit or provided via a validated home monitor within the prior 30 days is also required. The American Heart Association's validated device list is a reasonable reference for choosing a home monitor [11].
Summary of minimum labs before telehealth losartan initiation in Washington:
- Serum creatinine and eGFR
- Serum potassium
- Blood urea nitrogen (BUN)
- Blood pressure (in-visit or validated home reading within 30 days)
- Urine albumin-to-creatinine ratio (required for diabetic nephropathy indication; strongly recommended for patients with type 2 diabetes at any stage)
- Hemoglobin A1c or fasting glucose (for patients with diabetes or prediabetes)
Most Washington commercial labs, including Quest Diagnostics and LabCorp locations throughout Seattle, Spokane, and Tacoma, can process a BMP within 24 hours. Many telehealth platforms allow patients to order labs online before the visit, so results are available at the time of the consultation.
How to Get a Losartan Prescription Through Telehealth in Washington
Washington permits synchronous telehealth prescribing of losartan without a prior in-person relationship, as long as the prescriber meets the standard of care. The practical steps are straightforward.
Step 1. Book a video appointment with a Washington-licensed provider. The provider's license must show an active Washington State credential. Platforms that list providers by state make verification easy.
Step 2. Complete a health intake form covering your blood pressure history, current medications, kidney function, potassium levels (if known), and any prior ARB or ACE inhibitor use.
Step 3. Attend the synchronous video visit. The provider will review your BMP results, confirm your blood pressure readings, and discuss any contraindications such as pregnancy, bilateral renal artery stenosis, or concurrent potassium-sparing diuretic use.
Step 4. If the visit supports prescribing, the provider sends an electronic prescription to your preferred Washington-licensed pharmacy. Washington participates in the national PDMP (Prescription Drug Monitoring Program) through the PMP InterConnect network, though losartan is not a controlled substance and does not require a PDMP query [12].
Step 5. Pick up at a local pharmacy or choose mail-order delivery. Mail-order pharmacies licensed in Washington can ship a 90-day supply in most cases.
The 2024 telehealth parity rule under Washington SB 5789 requires that commercial insurers cover telehealth visits at parity with in-person visits for established conditions including hypertension [13]. That means most commercially insured Washington residents pay only a standard specialist or primary care copay for the telehealth visit.
Washington Pharmacy Options: Retail, Mail-Order, and 503A Compounding
Retail pharmacies. Generic losartan 50 mg tablets are available at every major chain pharmacy in Washington, including Walgreens, CVS, Rite Aid, and Bartell Drugs (a regional chain with 67 locations in the greater Seattle area). GoodRx pricing for a 30-count supply of losartan 50 mg at Washington pharmacies ranges from approximately $4 to $16 at press time, though prices fluctuate.
Mail-order pharmacies. Express Scripts, OptumRx, and Amazon Pharmacy all hold Washington-state dispensing licenses and can ship losartan to a Washington address. A 90-day supply typically arrives within 3 to 5 business days from the date the prescription is verified.
503A compounding pharmacies. Washington licenses 503A pharmacies under RCW 18.64 and WAC 246-878. A 503A pharmacy may compound a losartan preparation for an individual patient when there is a documented clinical need, such as a patient requiring a non-standard dose form (for example, an oral suspension for a patient with dysphagia). The FDA and Washington State Pharmacy Quality Assurance Commission (PQAC) both require that compounded preparations not be essentially a copy of a commercially available product [14]. Because standard losartan tablets are commercially available in 25 mg, 50 mg, and 100 mg strengths, most patients do not qualify for compounding. Patients with a documented swallowing disorder or pediatric dosing requirement (losartan is FDA-approved for pediatric hypertension down to age 6) may have a legitimate clinical basis for a compounded suspension [5].
Washington Medicaid and Insurance Coverage for Losartan
Washington Apple Health (Medicaid) covers losartan for hypertension, heart failure, and diabetic nephropathy, but requires prior authorization (PA) for the branded formulation Cozaar. The generic is available without PA as a preferred agent on the Washington Medicaid preferred drug list [15].
The PA process for branded losartan under Washington Medicaid typically requires documentation that the patient has a confirmed diagnosis (ICD-10 code I10 for essential hypertension, I50 for heart failure, or N18 for chronic kidney disease with diabetes), a prescriber attestation that the generic was trialed and caused an adverse reaction or was clinically inadequate, and in some cases a specialist consultation note.
Commercial insurance coverage for generic losartan is nearly universal. A 2021 analysis in JAMA Internal Medicine found that generic ARBs appeared on the formulary of more than 98 percent of commercial drug plans reviewed across all 50 states [16]. Washington exchange plans (sold through Washington Healthplanfinder) must cover generic antihypertensives at Tier 1 or Tier 2 under state insurance rules.
Transferring an Existing Losartan Prescription to Washington
Patients moving to Washington from another state can transfer a losartan prescription to any Washington-licensed pharmacy. Because losartan is not a controlled substance, federal law (21 CFR Part 1306) does not restrict transfers, and Washington pharmacy rules allow a full remaining supply to be transferred [17].
Practical steps for a prescription transfer:
- Contact your new Washington pharmacy (in person, by phone, or through the pharmacy app) and provide the name and phone number of your prior pharmacy.
- The Washington pharmacy contacts the originating pharmacy directly; the patient does not need to handle paper documents.
- If the prescription has no remaining refills, the Washington pharmacy will contact your prescriber (or a new Washington telehealth prescriber) for a new Rx.
- Insurance plans may require a mid-cycle override if you transferred before your refill window opens. A brief call to member services usually resolves this within one business day.
Patients new to Washington who lack an established prescriber should book a telehealth visit as described above. Most telehealth platforms can issue a new 90-day prescription with one or more refills once the initial evaluation confirms that continuing losartan is appropriate.
Monitoring After Starting Losartan in Washington
The ACC/AHA 2022 guideline recommends rechecking serum creatinine and potassium 2 to 4 weeks after initiating an ARB, and again after any dose increase [8]. A rise in serum creatinine of up to 30 percent above baseline is considered acceptable and expected due to efferent arteriolar dilation; a rise above 30 percent warrants holding the dose and seeking nephrology input [18].
Blood pressure monitoring at home with a validated upper-arm cuff is recommended throughout therapy. The target blood pressure for most adults under the ACC/AHA guideline is below 130/80 mmHg [8]. For patients with diabetic nephropathy and UACR above 300 mg/g, the Kidney Disease Improving Global Outcomes (KDIGO) 2024 guidelines recommend a systolic target below 120 mmHg if tolerated, based on SPRINT trial data [19].
Hyperkalemia is the most clinically significant acute risk with losartan. Patients with eGFR below 45 mL/min/1.73m2, those taking potassium-sparing diuretics (spironolactone, eplerenone, triamterene), potassium supplements, or trimethoprim-sulfamethoxazole should have potassium rechecked within 7 to 14 days of starting losartan rather than the standard 2 to 4 weeks [20].
Losartan is absolutely contraindicated in pregnancy (FDA Pregnancy Category D for second and third trimesters). Washington telehealth prescribers are required to document pregnancy status or confirm that the patient is not pregnant before issuing a losartan prescription [5].
Cost Without Insurance in Washington
Generic losartan is among the least expensive antihypertensives available. At most Washington retail pharmacies, a 30-day supply of losartan 50 mg costs between $4 and $18 without insurance when a GoodRx or similar coupon is applied. A 90-day mail-order supply commonly costs between $10 and $30 total.
The losartan patent expired in 2010, and multiple generic manufacturers now supply the U.S. market. The FDA's current list of approved losartan potassium generics includes products from Teva, Aurobindo, Zydus, Sun Pharmaceuticals, and others [21]. This manufacturer competition keeps the cash price low even without insurance coverage.
Patients who remain uninsured can access losartan through Washington's prescription assistance infrastructure. The Washington State Health Insurance Pool and several county-level programs offer premium assistance, but for losartan specifically, the cash price is often low enough that assistance programs add minimal incremental value.
Frequently asked questions
›How do I get a losartan prescription in Washington?
›What labs are needed before losartan in Washington?
›Are there telehealth providers in Washington prescribing losartan?
›How long until I receive losartan in Washington?
›Can I transfer a losartan prescription to Washington?
›Are 503A pharmacies in Washington licensed to ship losartan?
›Who can prescribe losartan in Washington: MD vs NP vs PA?
›What documentation does prior authorization require in Washington?
›What is the usual starting dose of losartan for hypertension?
›Is losartan safe during pregnancy?
›What blood pressure target should I aim for on losartan?
References
- Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet. 2000;355(9204):637-645. https://pubmed.ncbi.nlm.nih.gov/10696996/
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension study (LIFE). Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Centers for Disease Control and Prevention. Hypertension prevalence in the U.S. https://www.cdc.gov/bloodpressure/facts.htm
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System state hypertension data. https://www.cdc.gov/brfss/index.html
- U.S. Food and Drug Administration. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s057lbl.pdf
- American Association of Nurse Practitioners. State practice environment. https://www.aanp.org/advocacy/state/state-practice-environment
- Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med. 2017;377(16):1585-1592. https://pubmed.ncbi.nlm.nih.gov/29045204/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- American Heart Association. Validated blood pressure measurement devices. https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home
- National Alliance for Model State Drug Laws. PMP InterConnect. https://www.cdc.gov/drugoverdose/pdmp/index.html
- Centers for Medicare and Medicaid Services. Telehealth policy and parity. https://www.cms.gov/medicare/coverage/telehealth
- U.S. Food and Drug Administration. Compounding laws and policies: 503A. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Washington State Health Care Authority. Apple Health preferred drug list. https://www.hca.wa.gov/billers-providers-partners/programs-and-services/apple-health-preferred-drug-list-pdl
- Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States. JAMA. 2016;316(8):858-871. https://pubmed.ncbi.nlm.nih.gov/27552619/
- U.S. Drug Enforcement Administration. 21 CFR Part 1306, prescriptions. https://www.ecfr.gov/current/title-21/chapter-II/part-1306
- Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Arch Intern Med. 2000;160(5):685-693. https://pubmed.ncbi.nlm.nih.gov/10724055/
- Kidney Disease Improving Global Outcomes. KDIGO 2024 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2024;105(3):S1-S69. https://pubmed.ncbi.nlm.nih.gov/38380734/
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. https://pubmed.ncbi.nlm.nih.gov/15295051/
- U.S. Food and Drug Administration. Drugs@FDA: Losartan potassium approved generics. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020386